Recent progress in the pharmacotherapy of Churg-Strauss syndrome

Immunology and Microbiology

• Churg-Strauss Syndrome 100%
• Vasculitis 66%
• Asthma 33%
• Immunosuppression 16%
• Tumor Necrosis Factor 16%
• Etanercept 16%
• Immunosuppressive Drug 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Remission 33%
• Asthma 33%
• Vasculitis 33%
• Immunosuppressive Agent 16%
• Methotrexate 16%
• Blocking Agent 16%
• Eosinophilia 16%
• Cotrimoxazole 16%
• Tumor Necrosis Factor 16%
• Etanercept 16%
• Small Vessel Vasculitis 16%